These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8428578)

  • 1. Promoter accessibility within the environment of the MHC is affected in class II-deficient combined immunodeficiency.
    Kara CJ; Glimcher LH
    EMBO J; 1993 Jan; 12(1):187-93. PubMed ID: 8428578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.
    Reith W; Satola S; Sanchez CH; Amaldi I; Lisowska-Grospierre B; Griscelli C; Hadam MR; Mach B
    Cell; 1988 Jun; 53(6):897-906. PubMed ID: 3133120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.
    Reith W; Siegrist CA; Durand B; Barras E; Mach B
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):554-8. PubMed ID: 8290561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.
    Zhou H; Glimcher LH
    Immunity; 1995 May; 2(5):545-53. PubMed ID: 7749985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Steimle V; Otten LA; Zufferey M; Mach B
    Cell; 1993 Oct; 75(1):135-46. PubMed ID: 8402893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene.
    Gönczy P; Reith W; Barras E; Lisowska-Grospierre B; Griscelli C; Hadam MR; Mach B
    Mol Cell Biol; 1989 Jan; 9(1):296-302. PubMed ID: 2467188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation.
    Reith W; Barras E; Satola S; Kobr M; Reinhart D; Sanchez CH; Mach B
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4200-4. PubMed ID: 2498880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains.
    Douhan J; Hauber I; Eibl MM; Glimcher LH
    J Exp Med; 1996 Mar; 183(3):1063-9. PubMed ID: 8642248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined immunodeficiency with defective expression in MHC class II genes.
    Griscelli C; Lisowska-Grospierre B; Mach B
    Immunodefic Rev; 1989; 1(2):135-53. PubMed ID: 2517209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression.
    Ting JP; Wright KL; Chin KC; Brickey WJ; Li G
    J Immunol; 1997 Dec; 159(11):5457-62. PubMed ID: 9548486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in bare lymphocyte syndrome.
    Kovats S; Drover S; Marshall WH; Freed D; Whiteley PE; Nepom GT; Blum JS
    J Exp Med; 1994 Jun; 179(6):2017-22. PubMed ID: 8195723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three in vivo promoter phenotypes in MHC class II deficient combined immunodeficiency.
    Kara CJ; Glimcher LH
    Immunogenetics; 1993; 37(3):227-30. PubMed ID: 8420831
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic complexity of regulatory mutants defective for HLA class II gene expression.
    Seidl C; Saraiya C; Osterweil Z; Fu YP; Lee JS
    J Immunol; 1992 Mar; 148(5):1576-84. PubMed ID: 1538137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.
    Durand B; Kobr M; Reith W; Mach B
    Mol Cell Biol; 1994 Oct; 14(10):6839-47. PubMed ID: 7935401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome.
    Kara CJ; Glimcher LH
    Science; 1991 May; 252(5006):709-12. PubMed ID: 1902592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
    Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
    Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.
    Villard J; Lisowska-Grospierre B; van den Elsen P; Fischer A; Reith W; Mach B
    N Engl J Med; 1997 Sep; 337(11):748-53. PubMed ID: 9287230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.
    Westerheide SD; Louis-Plence P; Ping D; He XF; Boss JM
    J Immunol; 1997 May; 158(10):4812-21. PubMed ID: 9144496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients.
    Stimac E; Urieli-Shoval S; Kempin S; Pious D
    J Immunol; 1991 Jun; 146(12):4398-405. PubMed ID: 1904083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.